Allozen Pharma Private Limited - Company Profile

It is a healthcare private limited company based in Bangalore, Karnataka, India, established in 2019.
2019 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Allozen Pharma Private Limited

Allozen Pharma Private Limited, a active private limited company, was established on 16 October 2019 in Bangalore, Karnataka, India. Engaging in medical & laboratory equipment within the trade sector, it holds CIN: U24290KA2019PTC128784. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹4.50 M.

Employing 26 professional, Its leadership includes Prafful Jain (Director), Atish Ashok Jain (Director). Past directors included Deepak Moolchand Jain, Ashutosh Bherumal Bhandari, Ashok Kumar Palresha. It holds ₹29.40 Cr open charges and ₹25.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No 49/3, Khata No 191, Sreegandhada Kaval, Sunkadakate, Yeshwantapura Hobli, Magadi, Road, Bangalore, Karnataka, 560091.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290KA2019PTC128784

  • Registration Number

    128784

  • Incorporation Date

    16 October 2019

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹4.50 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 4.50 M
  • Company Age 6 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 29.40 Cr
  • Satisfied Charges ₹ 25.00 Cr
  • Revenue Growth **** 25.91%
  • Profit Growth **** -49.85%
  • Ebitda **** 67.72%
  • Net Worth 25.31%
  • Total Assets **** 58.32%
Company report

Allozen Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Allozen Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Allozen Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Prafful Jain Director 16 Oct 2019 Current
Atish Ashok Jain Director 01 Oct 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 Aug 2021 Past
Pramod Abcsdd Director 23 Aug 2021 Past
Pramod Abcsdd Director 30 Nov 2022 Past
Pramod Abcsdd Director 23 Aug 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Allozen Pharma.

Allozen Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.91% increase. The company also saw a substantial fall in profitability, with a 49.85% decrease in profit. The company's net worth Soared by an impressive increase of 25.31%.

Allozen Pharma revenue growth over time
Allozen Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 25.91%
*******
*******
*******
*******
Revenue from Operations
*******
 27.80%
*******
*******
*******
*******
Total Assets
*******
 58.32%
*******
*******
*******
*******
Profit or Loss
*******
 -49.85%
*******
*******
*******
*******
Net Worth
*******
 25.31%
*******
*******
*******
*******
EBITDA
*******
 67.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Allozen Pharma?

In 2023, Allozen Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹294,001,000.00

Satisfied Charges

₹250,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 15.00 Cr
  • The Hongkong And Shanghai Banking Corporation Limited : 14.20 Cr
  • Hdfc Bank Limited : 0.20 Cr
Latest Charge Details
Date Lender Amount Status
26 Oct 2024 Hdfc Bank Limited ₹2.00 M Open
30 Jun 2022 The Hongkong And Shanghai Banking Corporation Limited ₹14.00 Cr Open
30 Jun 2022 The Hongkong And Shanghai Banking Corporation Limited ₹2.00 M Open
27 Feb 2020 Others ₹15.00 Cr Open
01 Feb 2025 Others ₹25.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Allozen Pharma?

Allozen Pharma has a workforce of 26 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Allozen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allozen Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Allozen Pharma
Recent Activity within the Organization
  • Charges

    A charge with Others of Rs. 15.00 Cr registered on 27 Feb 2020 with Charge ID 100327110 was modified on 29 May 2025. was recorded as a recent event.

  • Charges

    A charge registered on 01 Feb 2025 via Charge ID 101047279 with Others was fully satisfied on 29 Mar 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101047279 was registered on 01 Feb 2025. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 101030446 was registered on 26 Oct 2024. was documented.

  • Annual General Meeting

    Progress on Allozen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Allozen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Allozen Pharma Private Limited?

The CIN of Allozen Pharma Private Limited is U24290KA2019PTC128784.

Where is Allozen Pharma Private Limited headquartered?

Allozen Pharma Private Limited is headquartered at No 49/3, Khata No 191, Sreegandhada Kaval, Sunkadakate, Yeshwantapura Hobli, Magadi, Road, Bangalore, Karnataka, 560091.

When was Allozen Pharma Private Limited incorporated?

Allozen Pharma Private Limited was incorporated on 16 October 2019.

Who are the current directors of Allozen Pharma Private Limited?

The current directors of Allozen Pharma Private Limited are

What is the primary industry of Allozen Pharma Private Limited?

The primary industry of Allozen Pharma Private Limited is Trade.

Is Allozen Pharma Private Limited a listed company?

Allozen Pharma Private Limited is unlisted.

What is the capital structure of Allozen Pharma Private Limited?

The authorized capital of Allozen Pharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹4.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available